| abstract |
The present invention relates to a compound of formula (I) [Wherein R 1 to R 6 are defined herein. ] Or a pharmaceutically acceptable salt thereof. The invention also relates to compositions comprising compounds of formula (I) and the use of such compounds in the inhibition of mutant IDH proteins having neomorphic activity. The invention further relates to the use of compounds of formula (I) in the treatment of diseases or disorders associated with mutant IDH proteins, including but not limited to cell proliferation disorders such as cancer. |